数位糖尿病管理市场报告：2031 年趋势、预测与竞争分析

全球数位糖尿病管理市场的未来前景光明，在医院、家庭环境和诊断中心市场都存在机会。预计到 2031 年全球数位糖尿病管理市场规模将达到 344 亿美元，2025 年至 2031 年的复合年增长率为 10.8%。该市场的关键驱动因素是糖尿病盛行率的不断上升、技术进步以及云端基础的糖尿病管理企业解决方案的日益普及。

• Lucintel 预测，由于智慧胰岛素帮浦和胰岛素贴片在糖尿病管理中自我注射胰岛素的应用日益广泛，穿戴式装置将在预测期内继续占据较大的市场份额。
• 根据最终用途，医院将继续成为最大的细分市场，这得益于医院越来越多地采用数位技术进行远端患者监护，并且易于获得先进的数位糖尿病管理工具。
• 根据地区划分，预计北美将在预测期内实现最高增长，这归因于该地区对联网糖尿病管理设备的需求不断增加、糖尿病管理和肥胖应用程序的采用激增以及对自我糖尿病管理的认识不断增强。

数位糖尿病管理市场的策略性成长机会

技术主导的进步和消费行为的改变正在为数位糖尿病管理市场创造成长机会。关键发展重点领域日趋清晰，关键应用具有改变的潜力。在本文中，我们提出了五种策略选择供您考虑。

• 远端医疗和远端监控解决方案的扩展：成长机会在于远端医疗和远端监控解决方案的扩展。这些设备使医生能够进行虚拟访问，从而增加患者获得医疗服务的机会。随着远端医疗的普及，人们将越来越多地接受数位工具来支持远距糖尿病管理和增强患者参与度。
• 穿戴式科技的创新：先进的连续血糖监测仪（CGM）和智慧胰岛素笔是穿戴式科技的重大进步，将开启新的成长机会。与穿戴式装置协同工作的行动应用程式有可能改善糖尿病治疗效果。未来的穿戴式装置可能具有增强的功能和更高的准确性，从而为患者和医疗保健提供者带来更好的结果。
• 个人化糖尿病管理系统：基于人工智慧的个人化糖尿病照护系统的发展是真正有可能的。这些解决方案可以根据个人资讯提供有针对性的提案，从而更好地管理疾病。透过解决特定的患者问题，公司可以改善整体管理和健康结果。
• 数位化糖尿病教育计画的成长：这为数位化糖尿病教育计画带来了巨大的成长机会。这些项目可以为患者提供更好地管理病情所需的宝贵资讯、资源和支持。透过整合互动性和引人入胜的内容，数位教育计画可以提高患者的知识并改善糖尿病照护。

数位糖尿病管理市场的策略性成长机会集中在增强整合、扩大远端护理以及利用技术提供个人化解决方案。整合平台的发展、可穿戴技术的进步以及数位教育的投资可能会显着改善糖尿病管理。提供便利、个人化和更​​有效的照护可以再形成这个市场，同时使患者和医疗保健提供者都受益。

数位糖尿病管理市场驱动因素与挑战

数位糖尿病管理市场的成长受到影响其进步的各种因素和挑战的推动。市场条件受技术进步、经济因素和监管条件的影响。因此，本文对影响市场的关键驱动因素和挑战进行了分析。

数位化糖尿病管理市场受以下因素驱动：

• 技术进步：数位糖尿病管理市场受到各种技术进步的推动，例如改进的 CGM、AI 分析和穿戴式装置。这些发展将改善血糖监测、资料准确性和个人化护理，从而带来更好的患者治疗效果。
• 远端医疗的普及率不断提高：远端医疗服务的广泛应用正在扩大糖尿病治疗的机会。远端咨询和监控选项使患者更容易及时获得帮助，提高整体控制和依从性。
• 更加关注患者参与：人们越来越关注鼓励患者自我管理和提高参与度的数位平台。互动式应用程式和线上辅导程序鼓励患者积极参与糖尿病护理，从而提高对规定治疗方法的依从性。

数位化糖尿病管理市场面临的挑战包括：

• 资料隐私和安全问题：数位化糖尿病管理的一个关键挑战是保护病患资料的隐私和安全。随着收集到的健康资讯越来越多，人们开始担心资料外洩和未授权存取，这可能会影响患者的信任和采用。
• 监管障碍：新数位健康技术的监管要求和核准可能难以获得。监管障碍可能会减缓创新解决方案的引入并阻碍市场成长。
• 整合和互通性挑战：将新的数位工具整合到现有的医疗系统中并确保资料互通性面临挑战。缺乏标准化和相容性问题可能会阻碍数位化糖尿病护理解决方案的顺利采用。

数位糖尿病管理市场的成长受到多种驱动因素​​和若干挑战的影响。技术进步、远距远端医疗服务的日益普及以及对病人参与的关注是关键驱动因素，而资料隐私问题、监管障碍和整合困境则带来了重大挑战。为了加速数位化糖尿病管理的进步并改善糖尿病患者的护理，我们必须克服这些瓶颈并利用这些驱动因素带来的机会。

目录

第一章执行摘要

第 2 章全球数位糖尿病管理市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动因素与挑战

第 3 章 市场趋势与预测分析（2019-2031）

• 宏观经济趋势（2019-2024）与预测（2025-2031）
• 全球数位糖尿病管理市场趋势（2019-2024 年）与预测（2025-2031 年）
• 全球数位糖尿病管理市场（按产品）
  • 智慧型血糖仪
  • 持续血糖监测系统
  • 智慧胰岛素笔
  • 智慧胰岛素泵
  • 应用程式
• 全球数位糖尿病管理市场类型
  • 穿戴式装置
  • 手持装置
• 全球数位糖尿病管理市场（按最终用途划分）
  • 医院
  • 居家医疗
  • 诊断中心

第 4 章区域市场趋势与预测分析（2019-2031 年）

• 全球数位化糖尿病管理市场（按区域）
• 北美数位糖尿病管理市场
• 欧洲数位糖尿病管理市场
• 亚太数位糖尿病管理市场
• 世界其他地区数位糖尿病管理市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球数位糖尿病管理市场成长机会（按产品划分）
  • 全球数位糖尿病管理市场成长机会（按类型）
  • 全球数位糖尿病管理市场成长机会（按最终用途划分）
  • 全球数位糖尿病管理市场各区域成长机会
• 全球数位糖尿病管理市场的新趋势
• 战略分析
  • 新产品开发
  • 全球数位化糖尿病管理市场产能扩张
  • 全球数位糖尿病管理市场的企业合併
  • 认证和许可

第七章主要企业简介

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche
• Bayer
• Lifescan
• Dexcom
• Sanofi
• Insulet Corporation
• Ascensia Diabetes Care Holdings
• B Braun Melsungen

The future of the global digital diabetes management market looks promising with opportunities in the hospital, home setting, and diagnostic center markets. The global digital diabetes management market is expected to reach an estimated $34.4 billion by 2031 with a CAGR of 10.8% from 2025 to 2031. The major drivers for this market are the increasing prevalence of diabetes, technological advancements, and the growing adoption of cloud-based enterprise solutions for diabetes management.

• Lucintel forecasts that, within the type category, wearable devices will remain the larger segment over the forecast period due to the growing adoption of smart insulin pumps and insulin patches for self-insulin delivery for the management of diabetes.
• Within the end use category, hospitals will remain the largest segment due to the increasing adoption of digital technologies for remote patient monitoring and the easy availability of advanced digital diabetes management tools in hospitals.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the increasing demand for connected diabetes management devices, surging adoption of diabetes management and obesity apps, and growing awareness of self-diabetes management in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Digital Diabetes Management Market

The digital diabetes management market is evolving rapidly through various directions that will shape its future. Numerous innovative solutions and advanced technology integration have led to personalized and efficient approaches to managing diabetes.

• Artificial Intelligence Integration: Digital diabetes management tools are increasingly adopting artificial intelligence (AI). AI algorithms use data from continuous glucose monitors (CGMs) and other sources to offer personalized insights and recommendations. This development enhances prediction, allowing users to make better decisions regarding their diabetes management practices. AI-based tools are improving glucose prediction accuracy, thus enhancing overall disease control and patient outcomes.
• Growth of Wearable Technology: In digital diabetes management, wearable technology is becoming very popular, with examples including smart insulin pens and advanced CGMs. These wearables can monitor glucose levels in real time and deliver insulin automatically, thereby improving convenience and accuracy in managing diabetes. It is now simpler for individuals to monitor their sugar levels with the help of wearable technology, resulting in better patient involvement and improved health outcomes.
• Expansion of Telehealth Services: Diabetes care is being revolutionized by the expansion of telehealth services, which offer remote consultations and support. With digital platforms, patients can connect with healthcare providers without necessarily appearing in their offices, making the management of diabetes mellitus more accessible and convenient. This especially benefits those in remote or underserved areas, who now have better access to specialized care and improved overall diabetes management.
• Enhanced Data Interoperability: This trend is growing because it allows for seamless integration of diabetes management tools into electronic health records (EHRs) and other healthcare systems. It enables better coordination between patients and practitioners, facilitating more comprehensive and efficient care. Sharing enhanced data ensures that all members of the medical team always have the latest patient information, leading to better-informed decisions about treatment that result in improved patient outcomes.

The marketplace has been remodeled by these novel trends within digital diabetes care systems that embrace new technology and inventive solutions, thus improving patient welfare. Diabetes management is being drastically enhanced due to AI integration, wearable technology, telehealth services, data interoperability, and a focus on patient engagement. These trends aim to foster personalized accessibility and efficacy in managing diabetes, thereby significantly improving the health status of diabetes patients and changing the landscape of diabetes treatment.

Recent Developments in the Digital Diabetes Management Market

Recent developments in digital diabetes management have revolutionized diabetes monitoring and treatment. The application of advanced technologies such as wearable devices, mobile apps, and data analytics has led to better patient care and disease control. These improvements have enhanced real-time monitoring capabilities, personalized treatment plans, and increased overall patient involvement.

• Integration of Continuous Glucose Monitoring (CGM) Systems: The integration of continuous glucose monitoring (CGM) systems with mobile applications represents a significant advancement. CGMs provide real-time blood sugar readings that are sent to mobile apps for tracking purposes. With this development, patients can regularly check their blood sugar levels, enabling them to maintain better glycemic control and make more informed decisions about their care regimens. Seamless data sharing between CGMs and apps improves patient engagement and supports early interventions in diabetes.
• Dynamic Progress in Artificial Intelligence (AI) through Diabetic Care: Glucose data is analyzed and trends are predicted using artificial intelligence (AI). AI algorithms analyze CGM data and other sources to generate personalized suggestions or alerts. This technology enables better insulin dosing and more effective diabetes management by predicting glucose fluctuations before they occur. The overall treatment outcomes from AI in predicting and managing diabetes are improving, leading to more individualized care.
• Expansion of Telehealth Services: The expansion of telehealth services has changed how diabetes is managed by providing remote consultations and support. Patients can now consult medical practitioners without having to travel long distances, especially those who live in rural areas with limited access to health services. Telehealth platforms ensure continuous monitoring and timely check-ins, ensuring that patients receive the right support when it is most needed. This development improves accessibility and convenience for individuals managing diabetes.
• Increased Focus on Patient Engagement Platforms: Patient engagement platforms are becoming increasingly popular. Consequently, diabetes patients are being educated and empowered through interactive apps and digital coaching programs. These platforms have features that help monitor progress, set goals, and motivate users. As a result, patients are now adhering to treatment regimens, thereby enhancing their overall health.

The digital diabetes management market has recently undergone numerous changes that have made it more accurate and patient-friendly. Diabetes is monitored and managed differently today through combined glucose monitoring devices, AI-powered analytics, remote healthcare services, patient engagement systems, and smart insulin pens. Consequently, diabetic patients now have improved access to care, including real-time data provision, personalized recommendations, and better outcomes.

Strategic Growth Opportunities for Digital Diabetes Management Market

Technology-driven advancements and transforming consumer behavior have created opportunities for growth in the digital diabetes management market. Focused areas for development are becoming apparent, with key applications offering a potentially transformative experience. This article presents five strategic options to consider.

• Expansion of Telemedicine and Remote Monitoring Solutions: The opportunity for growth lies in expanding telehealth and remote monitoring solutions. These devices enable physicians to conduct virtual visits, thereby increasing access to healthcare services for patients. The increased acceptance of digital tools that support remote diabetes management and enhance patient involvement can be observed as more distance care is utilized.
• Innovation in Wearable Technology: Advanced continuous glucose monitors (CGMs) and smart insulin pens represent significant advancements in wearable technology that present new growth opportunities. Mobile applications that connect with wearable devices have the potential to improve diabetes treatment outcomes. Future wearables could include enhanced functionalities and increased accuracy, resulting in better outcomes for patients and providers.
• Personalized Diabetes Management Systems: Developing AI-based personalized systems for diabetes care is a viable possibility. Such solutions can offer accurate suggestions based on individual information, leading to better disease control. By addressing specific patient issues, companies can enhance overall management and health outcomes.
• Growth of Digital Diabetes Education Programs: This presents a significant growth opportunity for digital diabetes education programs. These programs can provide patients with valuable information, resources, and support necessary for better managing their condition. By incorporating interactive and engaging content, patient knowledge in digital education programs can be enhanced, leading to improved diabetes care.

Strategic growth opportunities in the digital diabetes management market focus on enhancing integration, expanding remote care, and leveraging technology for personalized solutions. The development of integrated platforms, advancements in wearable technology, and investments in digital education could lead to substantial improvements in diabetes management. More effective care offerings that are accessible and personalized can reshape this market while benefiting both patients and healthcare providers.

Digital Diabetes Management Market Driver and Challenges

The growth of the digital diabetes management market is influenced by various factors and challenges that impact its progress. The market landscape is shaped by technological advancements, economic factors, and regulatory considerations. Thus, this paper presents an analysis of major drivers and challenges affecting the market.

The factors driving the digital diabetes management market include:

• Technological Advancements: The digital diabetes management market is being driven by a range of technological advancements, including improved CGMs, AI analytics, and wearable devices. These developments boost glucose monitoring, data precision, and individualized care, thereby leading to better patient outcomes.
• Increased Adoption of Telehealth: The increasing uptake of telehealth services is widening access to diabetes treatment. Remote consultation and monitoring options are making it easier for patients to receive timely assistance, enhancing overall control and adherence.
• Growing Focus on Patient Engagement: There is an increasing focus on digital platforms that encourage patient self-management and improve engagement. Interactive applications and online coaching programs help individuals participate more actively in their diabetes care, resulting in greater compliance with prescribed treatment regimens.

Challenges in the digital diabetes management market include:

• Data Privacy and Security Concerns: A significant challenge in digital diabetes management is protecting the privacy and security of patient data. As more health information is collected, there are concerns about data breaches and unauthorized access, which can impact patient trust and adoption.
• Regulatory Hurdles: Navigating regulatory requirements and obtaining approvals for new digital health technologies can be difficult. Regulatory barriers may delay the introduction of innovative solutions and hinder market growth.
• Integration and Interoperability Issues: Challenges arise when integrating new digital tools into existing healthcare systems and ensuring data interoperability. Lack of standardization and compatibility issues may prevent the smooth use of digital diabetes care solutions.

Various drivers shape the growth of the digital diabetes management market, along with several challenges. Technological advancements, increased adoption of telehealth services, and a focus on patient engagement are its main drivers, while concerns over data privacy, regulatory hurdles, and integration dilemmas pose significant challenges. To foster progress in digital diabetes management and improve care for diabetic patients, we must overcome these bottlenecks and capitalize on the opportunities presented by these drivers.

List of Digital Diabetes Management Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital diabetes management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital diabetes management companies profiled in this report include-

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche
• Bayer
• Lifescan
• Dexcom
• Sanofi
• Insulet Corporation
• Ascensia Diabetes Care Holdings
• B Braun Melsungen

Digital Diabetes Management by Segment

The study includes a forecast for the global digital diabetes management market by product, type, end use, and region

Digital Diabetes Management Market by Product [Analysis by Value from 2019 to 2031]:

• Smart Glucose Meter
• Continuous Blood Glucose Monitoring System
• Smart Insulin Pens
• Smart Insulin Pumps
• Apps

Digital Diabetes Management Market by Type [Analysis by Value from 2019 to 2031]:

• Wearable Devices
• Handheld Devices

Digital Diabetes Management Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Home settings
• Diagnostic Centers

Digital Diabetes Management Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Digital Diabetes Management Market

Digital diabetes management has been experiencing significant recent advancements that have greatly influenced the approach to diabetes care globally. Patient monitoring, engagement, and treatment personalization are being enhanced by advanced technological integrations such as wearable devices, mobile apps, and artificial intelligence (AI). These innovations address the increasing need for efficient and user-friendly solutions for diabetes management, offering real-time data and insights to improve patient outcomes.

• United States: In the United States, there has been noticeable uptake of high-tech digital diabetes management platforms. For example, continuous glucose monitors (CGMs) can now be integrated with smartphone applications, enabling real-time glucose tracking and management. Moreover, analytics based on AI are improving predictive capabilities, facilitating personalized therapies. Teleservices, such as telehealth and digital diabetes coaching, have also grown, reinforcing proper disease control and improving patient relationships while increasing access to care.
• China: The expansion of mobile health (mHealth) applications and telemedicine is driving rapid growth in digital diabetes management in China. Local tech companies are designing sophisticated platforms that merge CGM data with health management apps, providing users with comprehensive diabetes control tools. Government initiatives have been implemented to promote the integration of digital health solutions into mainstream care delivery systems, enhancing access and encouraging widespread utilization of diabetes management technologies in urban and rural areas.
• Germany: Smart insulin pens and advanced CGMs have revolutionized digital diabetes management in Germany. The use of these devices has improved glucose monitoring accuracy and insulin delivery. Moreover, Germany emphasizes data interoperability to enable easy integration between EHRs and diabetes management tools. Consequently, this connection enhances coordination between medical practitioners and their clients, leading to better treatment outcomes for both patients who comply with prescribed medications and the physicians themselves.
• India: India has seen the expansion of digital diabetes management through affordable mobile applications and wearable technologies. To address the high prevalence of diabetes in India, these tools provide simple-to-use glucose monitoring and management solutions. In particular, the growth of telemedicine platforms is facilitating access to diabetes care in underserved and remote areas. Efforts are underway to boost digital literacy and integrate these innovations into conventional healthcare delivery systems.
• Japan: Through highly accurate CGMs and automated insulin delivery systems, Japan is advancing in digital diabetes management. The goal is to integrate these systems with national health databases to improve patient tracking and intervention efficiency. Moreover, Japan is exploring AI-driven predictive analytics and personalized diabetes interventions that will enhance clinical performance among patients and streamline healthcare services. Furthermore, more patient education avenues, such as online platforms, are now available for individuals managing this disease.

Features of the Global Digital Diabetes Management Market

Market Size Estimates: Digital diabetes management market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Digital diabetes management market size by product, type, end use, and region in terms of value ($B).

Regional Analysis: Digital diabetes management market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, end uses, and regions for the digital diabetes management market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the digital diabetes management market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the digital diabetes management market by product (smart glucose meter, continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, and apps), type (wearable devices and handheld devices), end use (hospitals, home settings, and diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Digital Diabetes Management Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Digital Diabetes Management Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Digital Diabetes Management Market by Product
  • 3.3.1: Smart Glucose Meter
  • 3.3.2: Continuous Blood Glucose Monitoring System
  • 3.3.3: Smart Insulin Pens
  • 3.3.4: Smart Insulin Pumps
  • 3.3.5: Apps
• 3.4: Global Digital Diabetes Management Market by Type
  • 3.4.1: Wearable Devices
  • 3.4.2: Handheld Devices
• 3.5: Global Digital Diabetes Management Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Home settings
  • 3.5.3: Diagnostic Centers

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Digital Diabetes Management Market by Region
• 4.2: North American Digital Diabetes Management Market
  • 4.2.1: North American Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.2.2: North American Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.3: European Digital Diabetes Management Market
  • 4.3.1: European Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.3.2: European Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.4: APAC Digital Diabetes Management Market
  • 4.4.1: APAC Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.4.2: APAC Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.5: ROW Digital Diabetes Management Market
  • 4.5.1: ROW Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.5.2: ROW Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Digital Diabetes Management Market by Product
  • 6.1.2: Growth Opportunities for the Global Digital Diabetes Management Market by Type
  • 6.1.3: Growth Opportunities for the Global Digital Diabetes Management Market by End Use
  • 6.1.4: Growth Opportunities for the Global Digital Diabetes Management Market by Region
• 6.2: Emerging Trends in the Global Digital Diabetes Management Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Digital Diabetes Management Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Digital Diabetes Management Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Medtronic
• 7.3: F. Hoffmann-La Roche
• 7.4: Bayer
• 7.5: Lifescan
• 7.6: Dexcom
• 7.7: Sanofi
• 7.8: Insulet Corporation
• 7.9: Ascensia Diabetes Care Holdings
• 7.10: B Braun Melsungen